全文获取类型
收费全文 | 1540篇 |
免费 | 22篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 9篇 |
妇产科学 | 3篇 |
基础医学 | 85篇 |
口腔科学 | 7篇 |
临床医学 | 174篇 |
内科学 | 991篇 |
皮肤病学 | 3篇 |
神经病学 | 22篇 |
特种医学 | 13篇 |
外科学 | 115篇 |
综合类 | 34篇 |
预防医学 | 19篇 |
眼科学 | 23篇 |
药学 | 22篇 |
中国医学 | 1篇 |
肿瘤学 | 17篇 |
出版年
2023年 | 41篇 |
2022年 | 70篇 |
2021年 | 102篇 |
2020年 | 89篇 |
2019年 | 77篇 |
2018年 | 97篇 |
2017年 | 24篇 |
2016年 | 22篇 |
2015年 | 27篇 |
2014年 | 171篇 |
2013年 | 107篇 |
2012年 | 57篇 |
2011年 | 56篇 |
2010年 | 50篇 |
2009年 | 61篇 |
2008年 | 74篇 |
2007年 | 77篇 |
2006年 | 84篇 |
2005年 | 47篇 |
2004年 | 38篇 |
2003年 | 23篇 |
2002年 | 11篇 |
2001年 | 15篇 |
2000年 | 23篇 |
1999年 | 23篇 |
1998年 | 16篇 |
1997年 | 16篇 |
1996年 | 10篇 |
1995年 | 5篇 |
1994年 | 10篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 6篇 |
1990年 | 1篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 2篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1978年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有1570条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
《Biomaterials》2015
Bacterial infection of subcutaneous “pockets” housing cardiovascular implantable electronic devices is a significant clinical complication. In this study, pacemakers encapsulated in a blood plasma-based material (PBM) composited with antibiotics were investigated for use as prophylactics against such infections. PBMs, which are made from pooled allogeneic plasma and platelets, are off-the-shelf biomaterials that can be manufactured in the form of complex 3D shapes, extrudable putties, or injectable pastes. In vitro studies with PBM pastes formulated with rifampicin and minocycline demonstrated antibiotic release over 6 days, activity against Escherichia coli, and reduced cytotoxic effects of the antibiotics on fibroblasts. The materials were also evaluated in vivo in a rabbit model in which pacemaker pockets were inoculated with methicillin-resistant Staphylococcus aureus (S. aureus) strain and examined 1 week later. The pockets containing the pacemaker plus S. aureus were grossly purulent and culture positive, whereas pockets into which PBM with antibiotics were injected around the pacemaker were free of purulence and culture negative (p < 0.001). None of the pockets into which PBM without antibiotics were placed demonstrated purulence, but 60% were culture positive. These results demonstrate the potential of PBMs to deliver antibiotics to diminish the incidence of pocket infections for pacemakers and other implantable devices. 相似文献
6.
7.
8.
GIUSEPPE BORIANI MAURO BIFFI MAURIZIO RUSSO† MAURIZIO LUNATI‡ GIANLUCA BOTTO¶ ALESSANDRO PROCLEMER§ GIUSEPPE VERGARA WERNER RAHUE†† CRISTIAN MARTIGNANI RENATO RICCI† MASSIMO SANTINI† On Behalf of the SEARCH MI Registry Italian Investigators 《Pacing and clinical electrophysiology : PACE》2006,29(S2):S29-S34
Background: Large randomized trials show that in appropriately selected patients with left ventricular dysfunction, implantable cardioverter-defibrillators (ICDs) can improve overall survival at 2–5 years. Since direct implementation of the criteria used in the MADIT II and SCD-HeFT will lead to a marked rise in ICD implants, there is a growing fear that increased use of ICDs may cause a dramatic burden to health care systems. The ICD has traditionally been seen as an expensive form of treatment, which is difficult to accept at the first look. This is mainly due to the nonlinear character of the ICD investment, characterized by high initial expenditure, followed by a deferred pay-off in terms of clinical benefits. Cost-effectiveness analysis may help provide a different perspective on the problem of ICD cost, as may estimation of the daily cost of ICD treatment, assuming a time horizon of 5–7 years—a particularly interesting subject for further registry studies.
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
9.
A new implantable bladder volume-monitoring device based on the impedance measurement of the detrusor muscle is described.
The system is completely autonomous and forms a mixed-signal (analogue/digital) feedback loop with a neuro-stimulator to rectify
bladder dysfunctions (incontinence and retention) through neuromuscular stimulation techniques. A programmable instrumentation
amplifier and a signal processing block, to eliminate the artefacts caused by the patient’s movements, have been designed
and tested. The layout for the signal processing block has been realised in 0.8 μm BiCMOS technology. 相似文献